These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34971615)

  • 101. Trends in contraceptive use according to HIV status among privately insured women in the United States.
    Haddad LB; Monsour M; Tepper NK; Whiteman MK; Kourtis AP; Jamieson DJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):676.e1-676.e11. PubMed ID: 28866122
    [TBL] [Abstract][Full Text] [Related]  

  • 102. State-Identified Implementation Strategies to Increase Uptake of Immediate Postpartum Long-Acting Reversible Contraception Policies.
    Kroelinger CD; Morgan IA; DeSisto CL; Estrich C; Waddell LF; Mackie C; Pliska E; Goodman DA; Cox S; Velonis A; Rankin KM
    J Womens Health (Larchmt); 2019 Mar; 28(3):346-356. PubMed ID: 30388052
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Effect of an educational script on postpartum contraceptive use: a randomized controlled trial.
    Tang JH; Dominik RC; Zerden ML; Verbiest SB; Brody SC; Stuart GS
    Contraception; 2014 Aug; 90(2):162-7. PubMed ID: 24833047
    [TBL] [Abstract][Full Text] [Related]  

  • 104. The association between the COVID-19 pandemic and postpartum care provision.
    Sakowicz A; Matovina CN; Imeroni SK; Daiter M; Barry O; Grobman WA; Miller ES
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100460. PubMed ID: 34403823
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Educational Multimedia Tool Compared With Routine Care for the Uptake of Postpartum Long-Acting Reversible Contraception in Individuals With High-Risk Pregnancies: A Randomized Controlled Trial.
    Qureshey EJ; Chauhan SP; Wagner SM; Batiste O; Chen HY; Ashimi S; Ross PJ; Blackwell SC; Sibai BM
    Obstet Gynecol; 2022 Apr; 139(4):571-578. PubMed ID: 35594122
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Association of rural location and long acting reversible contraceptive use among Oregon Medicaid recipients.
    Rodriguez MI; Meath T; Huang J; Darney BG; McConnell KJ
    Contraception; 2021 Nov; 104(5):571-576. PubMed ID: 34224694
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Unintended pregnancy and subsequent postpartum long-acting reversible contraceptive use in Zimbabwe.
    Nance N; Ralph L; Padian N; Cowan F; Buzdugan R; Mushavi A; Mahomva A; McCoy SI
    BMC Womens Health; 2018 Nov; 18(1):193. PubMed ID: 30477497
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Unmet need for postpartum long-acting reversible contraception in women with substance use disorders and/or socioeconomic disadvantage.
    Best E; Lokuge B; Dunlop A; Dunford A
    Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):304-309. PubMed ID: 33619725
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Prevalence of long-acting reversible contraceptive methods utilization and associated factors among counseled mothers in immediate postpartum period at Jimma University medical center, Ethiopia.
    Arero WD; Teka WG; Hebo HJ; Woyo T; Amare B
    Contracept Reprod Med; 2022 Sep; 7(1):17. PubMed ID: 36050794
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Patients and providers' knowledge, attitudes, and beliefs regarding immediate postpartum long-acting reversible contraception: a systematic review.
    Thompson EL; Vamos CA; Logan RG; Bronson EA; Detman LA; Piepenbrink R; Daley EM; Sappenfield WM
    Women Health; 2020 Feb; 60(2):179-196. PubMed ID: 31122167
    [TBL] [Abstract][Full Text] [Related]  

  • 111. South Carolina immediate postpartum long acting reversible contraception program helps patients receive the contraceptive method they desire.
    Burgis JT; Tomlin KV; Allen KC; Mather A; Kimsey J
    Contraception; 2020 Jan; 101(1):62. PubMed ID: 31520607
    [No Abstract]   [Full Text] [Related]  

  • 112. Are Wisconsin resident physicians trained in immediate postpartum long acting reversible contraception?
    Rivas K; Schmuhl NB; Taboada M; Godecker A; Brown H
    Contraception; 2021 Oct; 104(4):372-376. PubMed ID: 34081975
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Characterization of Medicaid policy for immediate postpartum contraception.
    Moniz MH; Dalton VK; Davis MM; Forman J; Iott B; Landgraf J; Chang T
    Contraception; 2015 Dec; 92(6):523-31. PubMed ID: 26452327
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Contraception After Delivery Among Publicly Insured Women in Texas: Use Compared With Preference.
    Potter JE; Coleman-Minahan K; White K; Powers DA; Dillaway C; Stevenson AJ; Hopkins K; Grossman D
    Obstet Gynecol; 2017 Aug; 130(2):393-402. PubMed ID: 28697112
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Increasing access to immediate postpartum contraceptive implants: a prospective clinical trial among patients with opioid use disorder.
    Krans EE; Chen BA; Rothenberger SD; Bogen DL; Jones K; Turocy MJ; Klocke LC; Schwarz EB
    Eur J Contracept Reprod Health Care; 2022 Dec; 27(6):478-485. PubMed ID: 36062524
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Continuous quality improvement strategy for increasing immediate postpartum long-acting reversible contraceptive use at Jimma University Medical Center, Jimma, Ethiopia.
    Sori DA; Debelew GT; Degefa LS; Asefa Z
    BMJ Open Qual; 2023 Feb; 12(1):. PubMed ID: 36796864
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Changes in postpartum contraception utilization rates during the early stage of the COVID-19 pandemic.
    Chin E; Leung K; Moore Simas TA; Kumaraswami T
    Womens Health (Lond); 2023; 19():17455057231175311. PubMed ID: 37334467
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Interpregnancy Interval in a Rural Guatemalan Population: Results from a Quality Improvement Database.
    Harrison MS; Montes SB; Rivera C; Nacht A; Zambrano AJ; Lamb M; Bolanos A; Asturias E; Berman S; Heinrichs G
    Matern Child Health J; 2020 Aug; 24(8):1038-1046. PubMed ID: 32405739
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Intentionally or Ambivalently Risking a Short Interpregnancy Interval: Reproductive-Readiness Factors in Women's Postpartum Non-Use of Contraception.
    Rendall MS; Harrison EY; Caudillo ML
    Demography; 2020 Jun; 57(3):821-841. PubMed ID: 32096094
    [TBL] [Abstract][Full Text] [Related]  

  • 120. A cross-sectional study of factors associated with immediate postpartum uptake of contraceptive implants in Papua New Guinea.
    Black KI; Trane W; Dorney E; Mola G
    Contraception; 2023 Jan; 117():25-29. PubMed ID: 36252651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.